Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Big Money Flowing Into Biotech Stocks - Again
Forbes
Tue, 06/20/17 - 10:51 pm
Tags:
biotech, Valeant Pharmaceutials, Gilead Sciences
FDA approves Teva's generic copy of Truvada
BioPharma Dive
Wed, 06/14/17 - 09:04 pm
Tags:
FDA, Teva Pharmaceutical, generics, Truvada, HIV, Gilead Sciences
Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Fierce Pharma
Mon, 06/12/17 - 09:40 pm
Tags:
Sanofi, Gilead Sciences, Tesaro, M&A
Gilead racing to FDA with a new HIV cocktail boasting megablockbuster potential
Endpoints
Thu, 06/1/17 - 09:14 am
Tags:
Gilead Sciences, FDA, HIV, FTC/TAF
7 Things You Didn't Know About Gilead Sciences, Inc.
Motley Fool
Mon, 05/29/17 - 11:56 am
Tags:
Gilead Sciences, GSK, cash flow, IPOs, Warren Buffett
Gilead needs to best Glaxo with bictegravir
EP Vantage
Thu, 05/18/17 - 12:14 am
Tags:
Gilead Sciences, GSK, bictegravir, Dolutegravir, HIV
Glaxit: Flagging a looming threat from Gilead and a weak pipeline, Neil Woodford is giving up on GSK and pulling out
Endpoints
Fri, 05/12/17 - 09:44 am
Tags:
Gilead Sciences, GSK, ViiV
Gilead Vs. AbbVie: A DGI Thunderdome Match
Seeking Alpha
Mon, 05/8/17 - 09:55 pm
Tags:
Gilead Sciences, AbbVie
So what’s holding back Pfizer and Gilead from the really big M&A deals we’ve all been waiting for?
Endpoints
Wed, 05/3/17 - 10:54 am
Tags:
Pfizer, Gilead Sciences, M&A
Gilead (GILD) Misses Q1 Earnings and Revenue Estimates, Stock Drops
Yahoo/Zacks.com
Wed, 05/3/17 - 10:18 am
Tags:
Gilead Sciences, earnings
3 Big Drugmakers That Could Make Billions Under Trump's Tax Plan
Motley Fool
Mon, 05/1/17 - 11:48 am
Tags:
Donald Trump, taxes, JNJ, Pfizer, Gilead Sciences
3 Things to Watch With Gilead Sciences, Inc. Q1 Results
Motley Fool
Sun, 04/30/17 - 12:52 pm
Tags:
Gilead Sciences, earnings, hepatitis C, Genvoya, R&D
Should Gilead Sciences Be Worried About Allergan?
Motley Fool
Mon, 04/24/17 - 09:59 am
Tags:
Gilead Sciences, Allergan, NASH, GS-4997, Cenicriviroc, evogliptin
Gilead works on lifecycle management for Sovaldi as Hep C franchise wanes
BioPharma Dive
Thu, 04/13/17 - 11:48 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
3 Big Drugmakers Most Likely to Buy Incyte
Motley Fool
Wed, 04/12/17 - 11:57 am
Tags:
Incyte, M&A, Gilead Sciences, Amgen, Bristol-Myers Squibb
In Biotech, Biogen, Gilead, Alexion Earnings Will Steal The Spotlight
Barron's
Wed, 04/12/17 - 11:03 am
Tags:
biotech, earnings, Biogen, Gilead Sciences, Alexion
Would Gilead Sciences Make This Staggeringly Audacious Move?
Motley Fool
Sun, 04/9/17 - 12:27 pm
Tags:
Gilead Sciences, M&A, Celgene, Incyte
Gilead Hep C Drugs Get Supplemental FDA Nod
Investopedia
Sat, 04/8/17 - 01:11 pm
Tags:
Gilead Sciences, hepatitis C, FDA, Harvoni, Sovaldi
The Worst-Case Scenario for Gilead Sciences, Inc.
Motley Fool
Sat, 04/1/17 - 08:06 am
Tags:
Gilead Sciences, M&A, hepatitis C, HIV
Should the US government license hep C drugs?
BioPharma Dive
Fri, 03/31/17 - 09:55 pm
Tags:
hepatitis C, Merck, Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.